.RESEARCH STUDY FEATURE.06 August 2024.
A sizable randomized controlled trial along with cisgender ladies highlights the problems of fidelity to a daily dental preexposure prevention regiment as well as demonstrates that twice-yearly treatment of lenacapavir may preserve helpful HIV protection degrees over 6 months.